Wird geladen...
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer. The prognostic signature could be reliable to stratify LUAD patients according to risk, which helps the management of the systematic treatments. In this study, a systematic and reliable immune signature was performed...
Gespeichert in:
| Veröffentlicht in: | J Transl Med |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7060601/ https://ncbi.nlm.nih.gov/pubmed/32143735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02286-z |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|